Soluble Programmed Death Receptor Ligands sPD-L1 and sPD-L2 as Liquid Biopsy Markers for Prognosis and Platinum Response in Epithelial Ovarian Cancer

Soluble Programmed Death Receptor Ligands sPD-L1 and sPD-L2 as Liquid Biopsy Markers for Prognosis and Platinum Response in Epithelial Ovarian Cancer

Introduction: Response to platinum-based therapy is a major prognostic factor in epithelial ovarian cancer (EOC) and reliable prognostic biomarkers are urgently needed to identify patients at high risk. Since ligands of the Programmed Death Receptor-1 (PD-L1 and PD-L2) play a crucial role within the...

全面介绍

书目详细资料
Main Authors: Paul Buderath, Esther Schwich, Christina Jensen, Peter A. Horn, Rainer Kimmig, Sabine Kasimir-Bauer, Vera Rebmann
格式: 文件
语言:English
出版: Frontiers Media S.A. 2019-10-01
丛编:Frontiers in Oncology
主题:
epithelial ovarian cancer (EOC)
soluble PD-L1 (sPD-L1)
soluble PD-L2 (sPD-L2)
liquid biopsy
biomarkers
platinum therapy
在线阅读:https://www.frontiersin.org/article/10.3389/fonc.2019.01015/full

因特网

https://www.frontiersin.org/article/10.3389/fonc.2019.01015/full

相似书籍